U1 and systemic lupus erythematosus: SLE patients in the EA‐3 cluster, which showed lower disease activity, also had a significantly lower frequency of U1 RNP/Sm seropositivity and a trend toward lower rates of hypocomplementemia and dsDNA antibody positivity (not significant).